USA Chosen As Site For Diverse VCID Study

The University of South Alabama (USA) has been selected as a clinical site for a national research study on Alzheimer’s disease and other dementias, called diverse vascular contributions to cognitive impairment and dementia (VCID). The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, has commissioned a scientific team to design and implement a six-year study of 2,250 Americans from diverse backgrounds to understand the role cerebrovascular disease plays in developing dementia. UC Davis Health, along with UTHealth Houston, is leading the study. USA was awarded $1.26 million in funding over a four-year period to serve as a clinical site for the diverse VCID study. The award is part of a $53.6-million grant from NINDS to UC Davis. Dr. Amy R. Nelson, assistant professor of physiology and cell biology at the USA Frederick P. Whiddon College of Medicine, is principal investigator of the subcontracted research at USA.